Clozapin-Mepha 200 mg, Tabletten
7680669370039
CH-66937
Tabletten
Associated product:
Clozapin-Mepha cpr 200 mg, , Clozapin-Mepha cpr 200 mg 50 pce
1 / 3
google
Article details
- Package size
- 50
- Selling units
- 50
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
clozapinum
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
lactosum monohydricum
|
384.0 MG | Substance | HBESI |
|
maydis stylus
|
- | Substance | HNIDK |
|
povidonum K 30
|
- | Substance | HNIDK |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
talcum
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 49.40
Specialties list
Yes
Generic
Yes
SL addition date:
01/01/2019
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 66937
- Drug name
- Clozapin-Mepha, Tabletten
- Galenic form
- TAB
- ATC Code
- N05AH02
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 02/05/2018
- Authorization expiration date
- 01/06/2027
- IT Number
- 01.05.0.
- Domain
- Human medicine
Package details
- Description (FR)
- CLOZAPIN Mepha cpr 200 mg 50 pce
- Description (DE)
- CLOZAPIN Mepha Tabl 200 mg 50 Stk
- Market launch
- 02/05/2018
- Market withdrawal
- 09/12/2025
- Narcotic (BTM)
- No
Original drug
Leponex, Tabletten
GTIN: 7680374910124
CHF 17.60